Checkpoint Inhibitor-Associated Hypophysitis
KEY WORDScheckpoint inhibitors ipilimumab nivolumab immunotherapy hypophysitis
There are no additional contributors.
There are no funding sources, internal or external.
There are no prior presentations.
Compliance with Ethical Standards
Conflict of Interest
The authors declare that they have no conflict of interest.